Synopsis:
Chandan Healthcare partners exclusively with Jeena Sikho Lifecare to provide nationwide pathology and radiology services, enhancing affordable, technology-driven diagnostics and expanding Chandan’s presence across India’s healthcare network.
During Friday’s trading session, shares of a company running diagnostic centres in North India with pathology and radiology testing services hit a 5 percent upper circuit on NSE, after the company announced entering into a strategic partnership with Jeena Sikho Lifecare Limited to establish diagnostic centres.
With a market cap of Rs. 704 crores, the shares of Chandan Healthcare Limited hit a 5 percent upper circuit to a new 52-week high at Rs. 288 on NSE, as against its previous closing price of Rs. 274.3.
What’s the News
According to the latest filings with the NSE, Chandan Healthcare Limited has entered into an exclusive strategic partnership with Jeena Sikho Lifecare Limited to set up diagnostic centres across all existing and upcoming Jeena Sikho hospitals and clinics in India.
Under this partnership, Chandan Healthcare will serve as the exclusive diagnostic partner, providing comprehensive pathology and radiology services to both in-patient (IPD) and out-patient (OPD) departments across Jeena Sikho’s nationwide facilities.
The partnership is designed to deliver high-quality, affordable, and technology-driven diagnostic services accessible to patients across India, in alignment with both organizations’ shared mission of holistic and integrated healthcare delivery.
This collaboration is expected to expand Chandan Healthcare’s national presence and further strengthen its position as a leading provider of integrated healthcare solutions.
Financials & More
Chandan Healthcare reported a significant growth in its revenue from operations, showing a year-on-year increase of over 30 percent from Rs. 92 crores in H2 FY24 to Rs. 120 crores in H2 FY25. Likewise, its net profit increased during the same period from Rs. 8 crores to Rs. 12 crores, representing a rise of nearly 50 percent YoY.
Chandan Healthcare Limited is engaged in the business of delivering accurate, affordable, and comprehensive diagnostic services through a strong network of centres and collection facilities across North and Central India.
Listed on the stock exchange in 2025, the company recorded a turnover of Rs. 200 crore and expanded into new markets, including Rajasthan and Bihar, with further growth plans targeting Delhi, Raipur, and Bhopal.
Written by Shivani Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
